Loopbaan van K. Min
Eerdere bekende functies van K. Min
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LONGEVERON INC. | Algemeen Directeur | 01-06-2022 | 01-03-2023 |
| Hoofd Techniek/Wetenschap/O&O | 01-03-2023 | 30-06-2023 | |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Hoofd Techniek/Wetenschap/O&O | - | 01-04-2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Opleiding van K. Min
| Weill Cornell Medical College | Doctorate Degree |
| The Rockefeller University | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
| Bluerock Therapeutics, Inc. |
